» Authors » Walla Dempsey

Walla Dempsey

Explore the profile of Walla Dempsey including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 10
Citations 1199
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Asturias E, Connery A, Olson D, Lamb M, Paniagua-Avila A, Anderson E, et al.
Pediatr Infect Dis J . 2024 Dec; 44(4):290-298. PMID: 39637296
Background: Prenatal Zika virus (ZIKV) infection leads to microcephaly and adverse neurodevelopment. The effects of postnatal ZIKV infection on the developing brain are unknown. We assessed the neurodevelopmental outcomes of...
2.
Singh K, Rubenstein K, Callier V, Shaw-Saliba K, Rupert A, Dewar R, et al.
J Infect Dis . 2024 Apr; 230(3):624-634. PMID: 38657001
Background: Although antivirals remain important for the treatment COVID-19, methods to assess treatment efficacy are lacking. Here, we investigated the impact of remdesivir on viral dynamics and their contribution to...
3.
Wolfe C, Tomashek K, Patterson T, Gomez C, Marconi V, Jain M, et al.
Lancet Respir Med . 2022 May; 10(9):888-899. PMID: 35617986
Background: Baricitinib and dexamethasone have randomised trials supporting their use for the treatment of patients with COVID-19. We assessed the combination of baricitinib plus remdesivir versus dexamethasone plus remdesivir in...
4.
Kalil A, Mehta A, Patterson T, Erdmann N, Gomez C, Jain M, et al.
Lancet Respir Med . 2021 Oct; 9(12):1365-1376. PMID: 34672949
Background: Functional impairment of interferon, a natural antiviral component of the immune system, is associated with the pathogenesis and severity of COVID-19. We aimed to compare the efficacy of interferon...
5.
Kalil A, Patterson T, Mehta A, Tomashek K, Wolfe C, Ghazaryan V, et al.
N Engl J Med . 2020 Dec; 384(9):795-807. PMID: 33306283
Background: Severe coronavirus disease 2019 (Covid-19) is associated with dysregulated inflammation. The effects of combination treatment with baricitinib, a Janus kinase inhibitor, plus remdesivir are not known. Methods: We conducted...
6.
Laughlin C, Chakhtoura N, Beisel C, Dempsey W
J Infect Dis . 2020 Mar; 221(Suppl 1):S135-S137. PMID: 32134489
No abstract available.
7.
Jaenisch T, Hendrickx K, Erpicum M, Agulto L, Tomashek K, Dempsey W, et al.
BMC Med Res Methodol . 2018 Nov; 18(1):134. PMID: 30442099
Background: As increasing numbers of dengue vaccines and therapeutics are in clinical development, standardized consensus clinical endpoint definitions are urgently needed to assess the efficacy of different interventions with respect...
8.
Tomashek K, Wills B, Lum L, Thomas L, Durbin A, Leo Y, et al.
PLoS Negl Trop Dis . 2018 Oct; 12(10):e0006497. PMID: 30286085
Dengue is a major public health problem worldwide. Although several drug candidates have been evaluated in randomized controlled trials, none has been effective and at present, early recognition of severe...
9.
Krause P, Bryant P, Clark T, Dempsey W, Henchal E, Michael N, et al.
Sci Transl Med . 2015 May; 7(286):286ps11. PMID: 25947159
A December 2014 meeting reviewed Ebola virus immunology relevant to vaccine development, including Ebola prevention, immunity, assay standardization, and regulatory considerations. Vaccinated humans appear to achieve immune responses comparable in...
10.
Bernstein D, El Sahly H, Keitel W, Wolff M, Simone G, Segawa C, et al.
Vaccine . 2011 Aug; 29(43):7357-63. PMID: 21807052
Parvovirus B19 is an important human pathogen causing erythema infectiosum, transient aplastic crisis in individuals with underlying hemolytic disorders and hydropsfetalis. We therefore evaluated a parvovirus B19 virus like particle...